Feasibility Study of a Home Hospitalisation Strategy for Patients With Heart Failure
NWECHANCE
NWE CHANCE Feasibility Study of a Home Hospitalisation Strategy for Patients With an Acute Episode of Heart Failure Using Integrated eHealth Applications.
1 other identifier
interventional
66
1 country
1
Brief Summary
This feasibility study is part of a larger interregional European project (NWE-Chance) financially supported by the 'Interreg North West Europe' program to develop and validate promising integrated eHealth applications combined with nanotechnology for hospitalisation of heart failure patients at home. For more information on this research project and the partners see http://www.nweurope.eu/nwe-chance
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started Oct 2020
Shorter than P25 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2019
CompletedFirst Posted
Study publicly available on registry
September 10, 2019
CompletedStudy Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedMarch 15, 2022
March 1, 2022
1.1 years
September 5, 2019
March 14, 2022
Conditions
Outcome Measures
Primary Outcomes (5)
Acceptability will be assessed with the SUTAQ questionnaire adapted for home-hospitalisation
The SUTAQ or the Service User Technology Acceptability Questionnaire is to measure acceptability and identify the characteristics of persons who were likely to reject technological health services Will be assessed after the home-hospitalisation in patients and staff. There are 20 questions that can be answered with 6 answer possibilities ranging from fully disagree to fully agree. These answered will be coded to numbers ranging from 1-6 (6 is fully agree, 1 fully disagree). The total score is 120 and the range for the score can be 20-120
5-14 days
Usability will be assessed with the SUS questionnaire adapted for home-hospitalisation
SUS or the System Usability Scale will be used after the home-hospitalisation to assess the usability of the platform for the patients and staff. There are 10 questions in total with 5 answer possibilities ranging from totally agree to fully disagree. The answers will be coded to numbers (1-5) and 5 means totally agree and 1 is fully disagree. The total score is 50 and the range for the score can be 10-50
5-14 days
Satisfaction will be assessed with the Satisfaction Home-hospitalisation program questionnaire
The satisfaction of the home-hospitalisation program questionnaire consist of 19 questions and will be used to assess the satisfaction of patients. There are 5 answer possibilities ranging from completely satisfied to very dissatisfied. The answers will be coded to numbers (1-5) and 5 means completely satisfied and 1 is very dissatisfied. The total score is 95 and the range for the score can be 19-95
5-14 days
Platform use will be assessed with the amount of logs in the patient application
5-14 days
Number of adverse events will be mapped by the study team
30 days
Study Arms (1)
Study group
EXPERIMENTALThese patients receive the home-hospitalisation platform
Interventions
The primary objective of the INTERREG NWE-Chance project is the development of an integrated home-hospitalisation platform and the assessment of the feasibility of a home hospitalisation strategy for heart failure patients.
Eligibility Criteria
You may qualify if:
- Patients with known and well assessed chronic heart failure.
- Age\>18 years
- (Indication for) hospital admission for acute decompensated heart failure
- Living within a wide proximity of the hospital (differs per centre)
- Living independently and/or sufficiently supported at home and/or living in nursing homes (or other supported living modalities).
You may not qualify if:
- Indication for IC/CCU admission;
- Contraindication to Chance@Home;
- Mental impairment leading to inability to cooperate;
- Severe comorbidity requiring simultaneous hospital care;
- History of severe liver / kidney disease;
- Unstable blood pressure (systolic blood pressure \<90mmHg);
- Unstable heart rhythm (in case of sinus rhythm, heart rate \>110/min, in case of atrial fibrillation \>150/min);
- Need for intravenous inotropic medication;
- Unstable respiratory condition (sO2 \<90% without additional O2)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hasselt Universitylead
- Jessa Hospitalcollaborator
- Isalacollaborator
- Maastricht University Medical Centercollaborator
Study Sites (1)
Jessa Hospital
Hasselt, Belgium
Related Publications (1)
Leenen JPL, Scherrenberg M, Bruins W, Boyne J, Vranken J, Brunner la Rocca HP, Dendale P, van der Velde AE. Usability of a digital health platform to support home hospitalization in heart failure patients: a multicentre feasibility study among healthcare professionals. Eur J Cardiovasc Nurs. 2024 Mar 12;23(2):188-196. doi: 10.1093/eurjcn/zvad059.
PMID: 37294588DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 5, 2019
First Posted
September 10, 2019
Study Start
October 1, 2020
Primary Completion
November 1, 2021
Study Completion
December 1, 2021
Last Updated
March 15, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share